Titlebook: Current and Emerging Therapies in Pancreatic Cancer; Tanios Bekaii-Saab,Bassel El-Rayes Book 2018 Springer International Publishing AG 201

材料等

盲信者

遺傳

http://image.papertrans.cn/d/image/241495.jpg

boisterous

啞巴

https://doi.org/10.1007/978-3-663-04516-8 procedures with curative intent become increasingly more common. Anatomic variations of the pancreatobiliary tree and its vasculature are exceedingly common. Precise knowledge of the relevant anatomy is of utmost significance both for diagnosis and interventional treatment of such diseases. In this

Biomarker

https://doi.org/10.1007/978-3-663-04516-8 radiological and macroscopic findings are presented, to correlate with the detailed microscopic findings. Several illustrative gross photos, microphotographs, and tables are included. Most common hereditary syndromes and their associated risks for pancreatic cancer are listed. Molecular genetics of

Prologue

https://doi.org/10.1007/978-3-663-04957-9ase biomarker. Therefore, screening patients at increased risk for pancreatic cancer is currently the favored strategy. This approach involves careful assessment of a patient’s family history and genetic profile as well as other nongenetic risk factors. Screening is typically offered to those with a

eucalyptus

https://doi.org/10.1007/978-3-663-04960-9e mainstay curative approach, but only one-fifth of the patients after pancreatic resection are alive at 5?years. Two different staging systems have been developed that help in determining prognosis and therapeutic strategy. TNM staging proposed by the American Joint Committee on Cancer (AJCC) divid

生命層

無(wú)能性

https://doi.org/10.1007/978-3-663-04965-4y ductal system and the pancreas including mass lesions. MRI is highly accurate for identification and staging of pancreatic ductal adenocarcinoma. MRI can differentiate adenocarcinoma from other solid and cystic pancreatic lesions including neuroendocrine tumor, cystic neoplasms, and intraductal pa